ASSET PURCHASE AGREEMENT by and between LUCIRA HEALTH, INC. and PFIZER INC. dated as of April 12, 2023Asset Purchase Agreement • April 18th, 2023 • Lucira Health, Inc. • In vitro & in vivo diagnostic substances • Delaware
Contract Type FiledApril 18th, 2023 Company Industry JurisdictionTHIS ASSET PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of April 12, 2023 by and between Pfizer Inc., a Delaware corporation (“Buyer”) and Lucira Health, Inc., a Delaware corporation (“Seller”). Capitalized terms used but not defined in the context in which they are used shall have the respective meanings assigned to such terms in Section 12.14.